Home » Topics » BioWorld Science

BioWorld Science
RSS

Suzhou Ark Biopharmaceutical patents respiratory syncytial virus inhibitors

Aug. 24, 2021

New NLRP3 inflammasome inhibitors patented by Roche, Genentech

Aug. 24, 2021

Icahn School of Medicine at Mount Sinai presents new arylsulfonamide derivatives

Aug. 24, 2021

New SUMO-activating enzyme subunit 1 inhibitors identified at Oncovalent Therapeutics

Aug. 24, 2021

KalVista gains clinical trial approvals for phase II trial of KVD-824 for HAE

Aug. 23, 2021

Cytokine-induced JAK/STAT signaling plays role in cachexia

Aug. 23, 2021

Phase I data reported for GDC-3280 in healthy subjects

Aug. 23, 2021

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

Aug. 23, 2021

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...